@arcinstitute: The brain works hard to clear waste, and impairments are central to neurodegeneration. In @CellCellPress, Innovation In…
Summary
A new study in Cell maps how the brain clears waste, with implications for understanding neurodegeneration. Researchers tracked endogenous proteins to visualize waste removal pathways.
View Cached Full Text
Cached at: 05/29/26, 07:53 PM
The brain works hard to clear waste, and impairments are central to neurodegeneration. In @CellCellPress, Innovation Investigator @andcyang, w/ @NaliniRRao, Yuichi Chayama, and team map it from the inside out, following the brain’s own proteins to see where waste actually goes. https://t.co/NUuhLXiFCl
Similar Articles
@AnneliesGamble: https://x.com/AnneliesGamble/status/2066949973749755919
An exploration of why mapping the brain's connectome is valuable, arguing that unlike AI systems where design is in code outside weights, brains must encode all design physically, making architecture the key to understanding.
Loss of cell identity drives human aging: Two new papers
Two new papers, one in Nature by Vadim Gladyshev's Harvard team and one in Cell by Juan Carlos Izpisua Belmonte's Altos Labs group, propose a new 'loss of cell identity' model of aging alongside the classic wear-and-tear model, highlighting epigenetic drift and mesenchymal drift as potential targets for anti-aging interventions.
@arcinstitute: Neuronal proteins originating in the brain drained to the dura, skull, and nose, while injected CSF-tracer gathered in …
Neuronal proteins from the brain drain to the dura, skull, and nose, whereas injected CSF-tracer accumulates in neck lymph nodes. The study highlights that the act of injection may perturb the system under investigation.
Opening new paths in aging research
Calico Life Sciences uses Google DeepMind's Co‑Scientist to connect scattered findings in aging biology and generate testable hypotheses, such as a novel hypothesis about ISR regulation by metabolism.
There’s a New Link Between Gut Health and Alzheimer’s Disease
A study published in Nature Communications identifies imidazole propionate (ImP), a compound produced by gut bacteria, as a potential link between gut microbiome and Alzheimer's disease by weakening the blood-brain barrier and exacerbating amyloid beta and tau pathology.